Nalaganje...

Lessons from gefitinib-induced interstitial lung disease in Japan: Problems in approval, pharmacovigilance, and regulatory decision-making procedures

Objective: The objective of this study was to identifyproblems in the approval, pharmacovigilance, andpost-approval regulatory decision-makingprocedures involving gefitinib and to proposecountermeasures to prevent further drug-inducedsuffering in Japan in the future.Methods: We comprehensively revie...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Pharmacy Practice
Main Authors: Tsutomu Nishimura, Harue Tada, Masatsugu Nakagawa, Satoshi Teramukai, Shigeyuki Matsui, Masanori Fukushima
Format: Artigo
Jezik:Inglês
Izdano: Centro de investigaciones y Publicaciones Farmacéuticas 2006
Teme:
Online dostop:https://www.redalyc.org/articulo.oa?id=69040404
Oznake: Označite
Brez oznak, prvi označite!